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Macrothrombocytopenia-causing actinin-1 mutations 
 
Highlights: 
 Biochemical analysis of congenital macrothrombocytopenia causing actinin-1 
mutations 
 Calcium binding not consistently affected by CaM-like domain mutations 
 Mutations within the rod and CaM-like domains increase actinin-1 association with F-
actin 
 Similar effect to previously described mutations in the actinin-1 actin binding domain 





Actinin-1 mutations cause dominantly-inherited congenital macrothrombocytopenia (CMTP), 
with mutations in the actin-binding domain increasing actinin’s affinity for F-actin. In this study, 
we examined nine CMTP-causing mutations in the calmodulin-like and rod domains of actinin-1.  
These mutations increase, to varying degrees, actinin’s ability to bundle actin filaments in vitro.  
Mutations within the calmodulin-like domain decrease its thermal stability slightly but do not 
dramatically affect calcium binding, with mutant proteins retaining calcium-dependent 
regulation of filament bundling in vitro.  The G764S and E769K mutations increase cytoskeletal 
association of actinin in cells, and all mutant proteins colocalize with F-actin in cultured HeLa 
cells.  Thus, CMTP-causing actinin-1 mutations outside the actin-binding domain also increase 
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Introduction 
 
-Actinins (actinins) are actin-binding proteins which exist as antiparallel dimers consisting of an 
actin-binding domain (ABD), a carboxyl-terminal, calcium-binding calmodulin-like (CaM-like) 
domain and a central rod region (Fig. 1) [1].The rod domain mediates actinin dimerization and is 
comprised of four spectrin-like repeats (SR1-SR4) which connect the amino- and carboxyl-
terminal domains [2,3]. Actinin cross-links actin filaments, with major functions in cytokinesis, 
cell motility and adhesion [4,5].  The CaM-like domain comprises two pairs of EF hand motifs 
(EF1-2 and EF3-4) and in the non-muscle isoform of actinin-1 calcium binding to EF1 inhibits 
binding and cross-linking of actin filaments.  The recently described structure of the actinin-1 
CaM-like domain suggests that the binding of a single calcium ion to EF1 facilitates a 
restructuring of the EF3-4 region to a more open conformation, stabilising its binding to the 
“neck” region adjacent to the ABD of the opposing subunit and thereby regulating actinin’s 
interaction with F-actin [6].  
 
The platelet disorder congenital macrothrombocytopenia (CMTP) is characterised by a low platelet 
count (<150 x109 cells / L) and large platelet size resulting in a heightened bleeding risk of varying 
severity [7].  Recently described mutations in actinin-1 are thought to contribute to 5% of CMTP 
cases, making it the fourth most common cause of this disease [8,9]. To date, at least 37 likely 
CMTP-causing mutations in actinin-1 have been identified, with mutations in all of the functional 
domains having been described [8,10–17].  The residues mutated in actinin-1 linked CMTP are 
conserved in other actinin isoforms (actinin-2, -3 and -4) and hence are likely to have importance for 
all actinin isoforms [18]. CMTP-associated mutations in the actinin-1 ABD have been demonstrated 
to increase its affinity for F-actin, a molecular mechanism common to the inherited kidney disorder, 
focal and segmented glomerulosclerosis (FSGS) that is caused by actinin-4 mutations [19,20].  The 
consequences of mutations in the rod and CaM-like domain have not been examined at a molecular 
level. 
 
Although actinin-1 is widely expressed and has a broad range of cellular functions, it appears that 
actinin-1 mutations have consequences only in platelets [8], implying a tissue-specific role. Actinin-1 
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Genome wide association studies (GWAS) have implicated actinin-1 in platelet parameters including 
platelet size and platelet count indicating they play a role in platelet formation [23–25]. Actinin-1 
has an important role in cytokinesis, and has been implicated in endomitosis in megakaryocytes, the 
process whereby a failure of cytokinesis creates polyploid cells [26,27]. At later stages of platelet 
production, megakaryocytes display extension of cytoplasmic processes with platelet-sized buds, 
termed proplatelet tips, which are released into the vasculature [28]. Mutant actinin-1 proteins 
were shown to diminish the number of proplatelet tips and increase their size in an in vitro study 
[12]. However, analysis of megakaryocytes from affected individuals suggested proplatelet 
production was active but cells displayed large granules and the cytoplasm showed disorganisation 
[13].  Actinin-1 also plays important roles during platelet activation and can associate with other 
platelet activation components including integrin αIIbβ3, GpIb-IX-V, integrin β2 and signalling 
intermediates PI3K and PKN [29–33]. However, platelets isolated from individuals affected with 
actinin-1 related CMTP are functionally normal in terms of platelet activation [11,12]. Hence the 
molecular mechanisms underlying actinin-1 related CMTP have yet to be fully defined.  
 
In this study, we tested the hypothesis that CMTP-causing mutations in the CaM-like domain might 
affect calcium binding and, thus, the regulation of actinin-1’s association with F-actin.  However, we 
find that calcium binding is not consistently compromised and rather that actin-bundling ability in 
vitro and association with F-actin in cells is enhanced for three CaM-like domain mutations 
examined. In addition, we show that mutations in the rod domain can also enhance actin bundling 
ability in vitro. This gain of function phenotype is very similar to that seen for mutations affecting 
the ABD [20]. Hence, a common molecular mechanism appears to exist for most actinin-1 mutations 
implicated in CMTP, regardless of the affected protein domain. 
 
Materials & Methods 
Actinin-1 cDNA constructs   
The calcium-sensitive (non-muscle, exon 19a-containing) splice variant of human actinin-1 
was used in all experiments (Accession no. NM_001102).  Wild type (WT) and mutant 
actinin-1 constructs for both bacterial and mammalian expression were prepared as 
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domain encoded amino acids 740-892 of actinin-1 with an additional three amino acids (Gly-
Ser-Ser) at the amino terminus.      
 
Protein expression & purification  
Protein expression and removal of affinity tags was performed as described previously [20] except 
that an additional size exclusion chromatography step was performed using a Superdex 75 10/300 
GL column for CaM-like domain constructs and a Superdex 200 10/300 GL column for full-length 
actinin proteins on an AKTA Purifier 10 Fast Protein Liquid Chromatography system (GE Amersham).  
Proteins were eluted in filtered and degassed 100 mM NaCl, 20 mM HEPES pH 7.5 for CaM-like 
domains and 10 mM Tris pH7.5, 100 mM NaCl, 0.1 mM DTT for full length actinin proteins.  When 
necessary, proteins were concentrated using Amicon Ultra-4 Centrifugal Filters (Merck). For 
isothermal calorimetry and thermal shift assays, proteins were treated with Chelex-100 calcium 
binding resin (Sigma-Aldrich) for 2 - 16 hours at 4 ℃ prior to analysis. 
 
Thermal shift assays 
Purified actinin-1 CaM-like domain protein (20 µM) was mixed with Sypro Orange dye (Sigma-
Aldrich, S5692, used at a 1:250 dilution) in either the presence or absence of 1 mM CaCl2.  Samples 
were heated across a temperature range from 25 to 95 ℃ with a rate of change in temperature of 1 
℃ / min in a StepOne Plus Real Time PCR System (Applied Biosystems) while recording fluorescence 
at 1 min intervals using ROX Dye filter setting (Excitation at 488 nm with detection using a 615/30 
nm band pass filter). The fluorescence emission signal was plotted against temperature using 
Microsoft Excel software and an average plot was deduced for each protein. The melting 
temperature (Tm) of each protein in the presence and absence of CaCl2 was then deduced from a 
plot of minus the first derivative of fluorescence emission with respect to temperature, with the 
lowest point on this curve representing the Tm.   
 
Isothermal calorimetry 
Calcium binding efficiency was assessed with the Microcal PEAQ-ITC isothermal calorimeter 
(Malvern Panalytical) using purified actinin-1 CaM-like domains. 160-200 µM CaM-like domain 
protein in reaction buffer (100 mM NaCl, 20 mM HEPES pH 7.5) was loaded into the reaction 
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injection of 0.4 µL (4 seconds per injection), at 150 second intervals, and an initial delay of 60 
seconds, from a reservoir of 8 mM CaCl2 in identical reaction buffer. The reference cell contained 
reaction buffer.  Heat change was monitored from a baseline of 25 ℃ relative to increase in calcium: 
protein molar ratio. Sample results were analysed following subtraction of heat of dilution, which 
was obtained by measuring heat change when CaCl2 was added to reaction buffer without protein, 
using the same injection protocol. Dissociation constant (Kd), molar ratio of ligand to target (N), heat 
change (ΔH) and free energy change (ΔG) were calculated using Microcal PEAQ-ITC Analysis 
software (Malvern Panalytical).   
 
Actin co-sedimentation assays 
Actin co-sedimentation assays were performed essentially as previously reported [20,34] and are 
described as Supplementary Material accompanying this paper.  
 
Cytoskeletal purification assays 
Purification of cytoskeletal fractions from HeLa cells  was carried out largely as previously described 
[20,35], but a detailed description is provided as Supplementary Material.  
 
Immunofluorescence studies 
Sterile glass cover slips were air-dried in 6-well plates and coated with poly-L-lysine by incubation at 
room temperature for 1 hour, followed by rinsing with sterile PBS. HeLa cells (0.2 x 106 cells per 
well) were plated onto sterile cover slips and grown at 37 ℃ until 60% confluent. Transfection was 
carried out as described for cytoskeletal purification assays, using 2 μg Actinin-1-GFP plasmid. 36 
hours post transfection, cover slips were rinsed twice in PBS and fixed in 4% paraformaldehyde 
(PFA) on ice for 10 minutes. Coverslips were then rinsed again with PBS and blocked for 30 minutes 
at room temperature with blocking solution (5% normal goat serum, 2% BSA, 0.2% Triton). 
Following blocking and rinsing again in PBS, coverslips were stained with rhodamine phalloidin 
(1:3000) and DAPI (1:10,000) in blocking buffer without Triton for 1 hour at room temperature and 
then rinsed again with PBS. Coverslips were mounted on glass slides using Fluoromount (Sigma) and 
edges of coverslips were sealed with varnish. Images were acquired on a Leica DM6000 upright 
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researcher who was blinded to the identity of the transfected actinin proteins.  Measurements of 2-
4 phalloidin stained actin fibres in 5-7 cells per mutant protein were made using ImageJ software 
[36].  Local thresholding was performed for each fibre and a fibre segment 2-10 m long was 
defined using the “analyse particles” function.   Measurements of the area and length (taken as the 
Feret diameter) were made and the area divided by the length was used to calculate the average 
fibre width.   
 
Statistical analysis 




Actinin-1 CaM-like domains with CMTP-causing mutations have decreased thermal stability but 
maintain calcium binding ability. 
Three CMTP-linked mutations (R752Q, G764S and E769K) are located within the calcium-binding EF1 
region of the CaM-like domain of actinin-1.  R752Q is positioned in the middle of the first helix away 
from the calcium-binding site whereas both G764S and E769K are adjacent to residues directly 
involved in coordination of calcium (Supplemental Fig. 1B).  As a first step in the functional 
characterization of these mutations we examined the thermal stability of the isolated CaM-like 
domain using a thermal shift assay in which increased fluorescence of Sypro Orange dye gives a 
readout of protein unfolding.  In this assay both the WT and mutant proteins exhibited an 
unexpectedly high initial fluorescence signal that trended downwards as the temperature increased 
from 25 to approximately 55 ℃ (Fig. 2A).  This is possibly due to loose association between the dye 
and hydrophobic regions of the CaM-like domain.  Nevertheless, as the temperature climbed above 
60 ℃, a clear peak in fluorescence is observed that we interpret as corresponding to unfolding of the 
CaM-like domain, with increased Sypro Orange binding initially and its subsequent dissociation as 
the protein aggregates (Fig. 2B).  This interpretation is supported by the observation that this peak 
is shifted to the right in the presence of calcium, which would be expected to stabilize the CaM-like 
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Melting temperatures (Tm) for WT and mutant CaM-like domains in the presence and absence of 
calcium were determined from a plot of minus the first derivative of fluorescence emission with 
respect to temperature (Fig. 2C).  The Tm values of the mutant proteins were somewhat lower than 
the WT, both in the absence and presence of calcium (Fig. 2D).  These differences were statistically 
significant for the G764S and E769K mutants, implying that these mutants are less thermally stable 
than the WT protein.  Examining each individual protein in the presence and absence of calcium we 
found that Tm was significantly increased for all proteins in the presence of calcium, however while 
the extent of this increase was 8-10 ℃ for the WT, R752Q, G764S proteins it was only 4 ℃ for the 
E769K mutant. Thus, while some small differences in their thermal stability was observed, all the 
mutant proteins are capable of binding calcium.   
 
Calcium binding affinity of actinin-1 CaM-like domains is not dramatically affected by the G764S 
and R752Q CMTP-causing mutations. 
While thermal shift assays indicated that CaM-like domains with the R752Q, G764S and E769K 
mutations retained their ability to bind calcium it is possible that they differ quantitatively from the 
WT protein in their calcium binding affinity.  We therefore employed isothermal calorimetry to 
quantitatively assess calcium binding of WT and mutant actinin-1 CaM-like domain proteins.  The 
thermogram for the WT CaM-like domain protein shows a single endothermic event (Fig. 3A).  The 
binding stoichiometry (N) of 0.96 ± 0.15 for the WT protein implies a single binding event per CaM-
like domain molecule, and the calculated Kd of 114.94 ± 15.20 µM (Table 1) is in line with previous 
reports [6,37].  Melting profiles for G764S and R752Q proteins appeared similar to the WT and the 
calculated Kd and N values are also comparable, although variability between experimental 
replicates was somewhat greater than for the WT protein (Fig. 3B and 3C, Table 1). Hence calcium 
binding efficiency appears largely unaffected in the G764S and R752Q mutants. Thermograms for 
the E769K mutant differed substantially however, exhibiting DP and H values that are 
approximately 10-fold lower than for the other proteins (Fig. 3D).  Results from experimental 
replicates with different batches of E769K protein were highly variable which precluded the 












This article is protected by copyright. All rights reserved. 
CMTP-causing mutations in the rod and CaM-like domain enhance the F-actin bundling ability of 
actinin-1 
We next assessed the ability of full-length actinin-1 proteins with mutations in the CaM-like domain 
to bundle actin filaments in co-sedimentation assays.  We also examined proteins with the R738W 
mutation at the very end of SR4 and the L395Q mutation within SR2 of the rod domain 
(Supplemental Fig. 1C).  Analysing levels of actin and actinin-1 in the supernatants and pellets from 
these assays (Fig. 4A) it is apparent that the WT and all mutant actinin-1 proteins are able to bind to 
(Fig. 4B), and bundle (Fig. 4C) actin filaments in the absence of calcium.  These abilities are 
significantly decreased in the presence of calcium for all proteins implying that calcium sensitivity is 
maintained in full-length actinin-1 proteins harbouring CMTP-causing mutations.  Examining actin 
bundling in the absence of calcium it was found that all the mutant proteins assessed had a greater 
ability to bundle actin than WT actinin-1 (Fig. 4C).  This was statistically significant for one rod 
(L395Q), and two CaM-like domain (R752Q and E769K) mutations. By comparison, while the levels 
of bound actinin were generally higher for the mutants compared to the WT this was not 
statistically significant for any of the mutant proteins (Fig. 4B).   
The observation that mutations in the CaM-like and rod domains affect actin binding/bundling in a 
similar manner to ABD mutations is somewhat surprising, especially for the L395Q mutation given 
its location in the middle of the central rod domain.  This suggests that enhanced actin 
binding/bundling might be common to all CMTP-linked actinin-1 mutations and that actin bundling 
might be a functional assay that could distinguish pathogenic mutations from those of uncertain 
significance.  We therefore assessed actin bundling for another four rod domain mutations.  These 
included R320Q and L547P, located in SR1 and SR3 respectively, which are classified as likely 
pathogenic[16].  We also assessed two mutations of the same residue, one of which (T737N) is likely 
pathogenic [16,38], and the other (T737S) that was deemed to be a variant of unknown 
significance[8].  The R320Q, T737N and T737S mutant proteins all show a highly significant increase 
in actin bundling activity whereas a much smaller and not statistically significant increase was seen 
for L547P (Fig. 4D-4F).  These findings indicate that mutations throughout the rod domain can affect 
actin binding properties, albeit to varying extents, and that relatively conservative amino acid 
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CMTP-causing mutations in the CaM-like domain of actinin-1 increase the stability of its 
association with the actin cytoskeleton in cells.  
To assess if the increased actin-bundling of the CaM-like domain and rod domain mutants was 
evident in-cellula, the association of FLAG-tagged actinin-1 with F-actin in cytoskeletal fractions 
purified from cultured HeLa cells was examined for the L395Q, G764S and E769K mutations.   
Significantly increased actinin-1 in cytoskeletal fractions was observed for the two CaM-like domain 
mutations (G764S and E769K) compared to the WT protein (Fig. 5A), whereas an increase for rod 
domain mutation L395Q was very slight and not statistically significant.   
It has been reported that actinin-1 proteins with CMTP-linked mutations can disrupt the actin 
cytoskeleton and have an altered distribution in the cytosol of cultured megakaryocytes, 
human fibroblasts and CHO cells [8,10–13,17] whereas we did not find this to be the case in 
HeLa cells for FLAG-tagged proteins with mutations in the ABD for example [20]. To further 
examine this issue we transiently expressed WT GFP-tagged actinin-1 as well as two 
mutants affecting the ABD (V105I and E225K), two affecting the rod domain (L395Q and 
R738W) and three affecting the CaM-like domain (R752Q, G764S and E769K) in HeLa cells 
(Fig. 5C).  We then examined the localization of actinin-GFP in relation to the F-actin 
cytoskeleton.  The majority of transfected HeLa cells could not be distinguished from 
untransfected cells in terms of F-actin organization and consistent co-localization of both WT 
and all mutant actinin-1-GFP proteins with F-actin was observed, both in HeLa cells (Fig. 
5C) and differentiating MEG-01 megakaryoblast cells (Supplemental Fig. 2).  Quantification 
of the diameters of bundled actin fibres in HeLa cells did not reveal significant differences 
between cells expressing WT and mutant actinin-1 proteins (Fig. 5D), in contrast to a recent 
report using CHO cells for different CMTP-linked actinin-1 mutations [17]. Our findings 
suggest that, at least in HeLa cells, the mutant actinin-1 proteins examined here retain their 
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Discussion 
We previously demonstrated that CMTP-linked mutations in actinin-1 that occur in the ABD increase 
the protein’s affinity for and cross-linking of actin filaments [20].  Here, we have extended this 
analysis focusing on mutations in CaM-like and rod domains to ascertain whether they have similar 
effects on actin binding properties.  
 
Mutations in the CaM-like domain 
Three amino acids mutated in actinin-1-linked CMTP map to EF1 of the CaM-like domain, the only 
EF hand motif in actinin-1 that is functional in terms of calcium binding.  R752Q or R752P mutations 
have been reported in four families [8,11,12,16] while the G764S and E769K mutations have each 
been reported in a single family to date[11].  Calcium binding to EF1 is thought to cause structural 
stabilisation of the CaM-like domain of actinin-1 with a more open conformation of EF3-4 promoting 
its interaction with the neck region adjacent to the ABD of the opposing subunit in the actinin dimer 
and consequently impairing actinin’s ability to cross link F-actin, due to increased rigidity in the neck 
region [6].   
 
Thermal shift assays allowed us to examine the effects of CMTP-linked mutations on both the 
stability and calcium binding ability of the isolated CaM-like domain.  We observed high levels of 
fluorescence at room temperature for both the WT and mutant CaM-like domain in these 
assays(Fig. 2A). This may be due to factors such as the lack of a compact globular shape or the 
presence of exposed hydrophobic regions in a protein and has been reported to occur in 15-25% 
recombinant proteins [39,40]. Nevertheless, a peak in fluorescence that was observed for the WT 
protein as the temperature rose above 60 °C could be interpreted as corresponding to the thermal 
denaturation of the CaM-like domain on the basis that (1) it was shifted to the right in the presence 
of calcium (but not magnesium; data not shown) and (2) the observed Tm values of 74.8 and 85.1 °C 
in the absence and presence of calcium are in line with the high melting temperatures that have 
been reported for calmodulin and related EF-hand-containing proteins [41,42].  The Tm values for 
CaM-like domains with the G764S and E769K mutations were significantly lower than the WT 
protein both in the absence and presence of calcium.  This indicates that these mutations do affect 
the stability of the CaM-like domain although, given the high thermal stability of this domain, the 
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like domain, a statistically significant increase in Tm was seen for all three mutant proteins (R752Q, 
G764S and E769K) in the presence of calcium, indicating that they are able to bind and be stabilised 
by bound calcium ions.  For the R752Q mutant the magnitude of this shift was similar to the WT at 
approximately 10°C, whereas for the G764S and E769K mutants it was somewhat less at 8 and 4°C 
respectively.  This comparatively smaller shift is suggestive of less structural stabilisation due to sub-
optimal calcium binding and would fit with the location of the G764S and E769K mutations 
immediately adjacent to the calcium co-ordinating residues in EF1 (Supplemental Fig. 1B).    
 
Assessing calcium binding more quantitatively by isothermal calorimetry, we found that the WT 
CaM-like domain demonstrated a single binding event and a dissociation constant (114.94 ± 15.20 
µM) in line previous reports [6,37]. Similar average Kd values were calculated for the R752Q and 
G764S, albeit with greater variance in the data obtained for these mutants.  By contrast, binding 
efficiency appeared to be compromised in the E769K mutant for which DP and H values were 10-
fold lower then WT or other mutants.  This precluded the accurate calculation of a Kd value but 
suggests a significant deficiency in calcium binding for this mutant.  However, the high protein 
concentrations required for calorimetry experiments must be borne in mind as they may exacerbate 
changes in protein stability that might not be so significant under conditions of more physiological 
protein concentrations.   
 
In actin bundling assays full-length actinin-1 proteins harbouring these mutations all bundled actin 
more efficiently than the WT protein and this bundling was reduced in the presence of calcium, 
indicating that all the CaM-like domain mutant proteins retain their calcium-sensitivity in this 
context.  Cytoskeletal association of the G764S and E769K mutants in HeLa cells was also 
significantly enhanced, and all three mutants co-localized with actin filaments in both HeLa and 
differentiating MEG-01 megakaryoblast cells.  Overall our data on the CaM-like domain mutations 
indicates that the E769K mutation has the greatest impact on protein stability and affects, but does 
not abolish, calcium binding, whereas R752Q and G764S mutant proteins appear to be minimally 
affected in this regard.  In addition, enhanced bundling of and/or association with actin filaments is 
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Calcium-sensitive regulation of actin by actinin-1 and other proteins is relevant to key aspects of 
platelet function including platelet activation when intracellular calcium concentration doubles [43] 
and plays a role in driving dramatic changes in cell shape [44]. Given the mild phenotype and normal 
platelet activation reported for patients with actinin-1 associated CMTP, it is perhaps unsurprising 
that calcium-binding efficiency is not dramatically affected by the reported CaM-like domain 
mutations, as the loss of calcium regulation of actinin-1 would likely have severe consequences for 
platelet function and for other actinin-1 expressing cells [11,12]. 
 
Rod domain mutations 
A cluster of CMTP-linked mutations map to amino acids 737 and 738 that lie at the end of the last 
alpha helix of the 4th SR of the rod domain.  Four families with either T737N or T737S mutations and 
eight families with R738W or R738Q mutations have been reported [8,11,12,15,16].  Interestingly 
the T737S  mutation was classified as a variant of uncertain significance presumably due to, (1) its 
occurrence in a single family, (2) it being a relatively conservative substitution with low scores for its 
disruptive potential according to predictive bioinformatics algorithms and, (3) the lack of observed 
disruption of the actin cytoskeleton in cells transfected with actinin-1 harbouring this mutation [8].  
In the crystal structure of actinin-2 EF1-2 lies on top of and is in close contact with SR4 and the 
residues equivalent to T737 and R738 are close to this interface (Supplemental Fig. 1C) [1]. 
Mutations of these residues in actinin-1 may thus affect the interaction of SR4 with the CaM-like 
domain and alter its regulation of actin binding.  However, in the actinin-2 structure, while the 
equivalent threonine residue forms hydrogen bonds with residues from EF-2, the arginine side chain 
projects away from EF-2, not making close contact with the CaM-like domain.  Perhaps reflecting 
this, we find here that both the T737N and T737S mutations potently increased actinin-1’s ability to 
bundle actin filaments in vitro, whereas actinin-1 R738W shows only a slight increase in bundling 
activity that is not statistically significant (in agreement with our previous findings that showed a 
slight but not significant increase in cytoskeletal association for this mutant [20]).  These findings 
indicate that the T737S mutation has functional consequences, supporting the case for it being 
classified as a likely pathogenic mutation and also suggest that bundling assays may be a useful 
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In contrast to this cluster of mutations at the end of SR4, the R320Q, L395Q and L547P rod domain 
mutations that we examined are located some distance from the ABD and CaM-like domains 
(Supplemental Fig. 1D, 1E).  Based on the actinin-2 structure, R320 lies close to the dimer interface 
whereas L395 and L547 do not.  Nevertheless, all three mutant proteins elute as dimers from a gel 
filtration column (data not shown), and can bundle actin filaments, indicating that dimerization of 
the rod domain is not disrupted.  The R320Q and L395Q mutant proteins have dramatically 
increased actin bundling ability in vitro whereas actin bundling for L547P was not significantly 
increased compared to WT actinin-1.  The L395Q mutation maps to the first helix of SR2 in the 
middle of rod domain and in the actinin-2 structure the equivalent leucine residue is facing away 
from the dimer interface with its sidechain projecting towards helix 2 of SR2 (Supplemental Fig. 1D-
E).  The R320Q mutation maps to helix 2 of SR1.  The sidechain of the equivalent arginine residue in 
actinin-2 makes polar contacts with three glutamate residues, one located in SR4 of the other 
actinin subunit and two located in helix 3 of SR1 (Supplemental Fig. 1F).  Notably, helix 3 of SR1 
continues as an unbroken alpha helix to become helix 1 of SR2.  Thus, mutations such as R320Q and 
L395Q may be able to exert long distance effects through the long -helices of the spectrin repeats, 
thereby influencing the CaM-like domain’s regulation of actin binding and bundling.  Our current 
understanding of actin filament cross linking by actinin indicates that the 90 degree twist present 
within the rod domain is not compatible with the tight bundling of actin filaments in a parallel or 
anti-parallel orientation [1,3,6].  Such bundling of filaments into tight fibres probably requires 
dissociation of EF3-4 from the neck region to give this region the conformational flexibility required 
to re-orient the ABD appropriately [1].  It is conceivable then that mutations in the rod domain may 
influence the bundling of actin filaments either by altering the twist of the rod domain, or by long 
range structural effects that influence the “clamping” of the neck region by EF3-4.  A structure of 
the full-length actinin-1 dimer would greatly aid our understanding in this regard.      
 
Yasutomi et al [10] reported that CHO cells expressing actinin-1 L395Q exhibited disorganization of 
the actin cytoskeleton with shorter and thicker actin fibres and similar effects have previously been 
reported for other CMTP-linked actinin-1 mutations [8,11–13] and most recently for eleven newly 
identified mutations (including nine in the rod domain) [17].  We found that actinin-1 L395Q 
association with the cytoskeleton in cultured HeLa cells appears similar to that of WT actinin-1 in 
contrast to the CaM-like domain mutations G764S and E769K.  In addition, we did not observe 
notable cytoskeletal disruption, nor increased actin fibre diameter in HeLa cells for L395Q or the 
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properties in vitro and actin association/organization in-cellula is not straightforward and is likely to 
be cell line-specific.  We attempted to use differentiating MEG-01 megakaryoblast cells as a more 
relevant cellular model (Supplemental Fig. 2), but a high degree of intrinsic morphological 
heterogeneity in these cells complicated any analysis of the effects of transfected actinin-1 proteins.  
Primary cultures of rodent megakaryocytes are likely to be a better model to examine the 
mechanisms by which actinin-1 mutations affect platelet production.      
 
In summary, all the CaM-like and rod domain actinin-1 mutants assessed here show varying degrees 
of increased association with F-actin  in vitro and/or in vivo. This phenotype was demonstrated 
previously for several CMTP-causing mutations in the actinin-1 ABD [20].  A common mechanism 
thus appears to exist in the pathogenesis of actinin-1 related CMTP, regardless of the functional 
domain of actinin-1 affected. We hypothesise that some event(s) during platelet production, such as 
the extension of proplatelet shafts from megakaryocytes or the fission of large pre-platelets into 
mature platelets in the vasculature, may be exquisitely sensitive to a slightly increased affinity or 
bundling activity of actinin-1 for F-actin such that the CMTP-linked mutations affect platelets in the 
absence of any apparent phenotype in other tissues [45,46].  At the same time we cannot exclude 
the possibility that some of the CMTP-linked mutations might disrupt other protein: protein 
interactions that are essential for platelet formation, particularly given the many interacting 
proteins known to associate with the actinin-1 rod and other functional domains [47].  
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Tables 
 
Table 1: Thermodynamic parameters obtained in the analysis of calcium binding efficiency 
in WT and mutant actinin-1 CaM-like domains by isothermal calorimetry. 
 
Sample n Kd (µM) N ∆H ∆G T∆S 
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Figure Legends 
 
Figure 1 : Location of amino acids that are mutated in CMTP within the actinin protein 
structure.  
Domain organisation of the actinin-1 dimer showing the interaction of the CaM-like domain 
with the neck region of the opposing subunit that is thought to regulate actin binding [1,6,48].  
The approximate positions of selected CMTP-linked mutations are indicated by arrows.  Red 
arrows indicate the mutations in the rod and CaM-like (CaM) domains examined in this study, 
while black arrows represent mutations in the ABD that were previously shown to increase 
actinin-1 association with F-actin [20]. 
 
 
Figure 2 : Analysis of thermal stability and calcium binding of mutant actinin-1 CaM-like 
domains by thermal shift assay.  
(A) Representative plots of fluorescence verses temperature for WT and mutant CaM-like 
domain proteins in the absence (dark grey) and presence of 1 mM CaCl2 (light grey).  High 
initial fluorescence was seen for all proteins, with typical melting profiles seen as the 
temperature rose above 60 °C.  
(B) Average plots of melting profiles for all proteins (n = 7).  
(C) Derivative plots of average data where the lowest points on the curve correspond to 
melting temperature.  
(D) Analysis of melting temperatures in the absence and presence of calcium. All proteins 
exhibited increased thermal stability in the presence of calcium (significance level indicated 
above the brackets), while two mutants (G764S and E769K) had significantly lower melting 
temperatures than the WT protein under both conditions (significance level indicated above 
the error bars; n = 7; error bars represent SEM). Statistical analysis by One-Way ANOVA and 
post-hoc analysis by Dunnett’s Test was used to compare WT and mutant protein melting 
temperatures. The paired sample T-Test was used to compare melting temperatures for each 
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Figure 3 : Calcium binding affinity of WT and mutant actinin-1 CaM-like domains assessed by 
isothermal calorimetry.  
CaCl2 was titrated against WT or the indicated mutant CaM-like domain proteins by injections 
of equal volume at regular time intervals. The top graph in each case shows the raw data as a 
function of time; the heat of the binding reaction is monitored as the differential power (DP) 
(µcal/s) required to maintain the experimental cell at the same temperature (25 °C) as the 
reference cell. The lower graph shows the processed data after normalization per mol of 
injectant, integration with respect to time and subtraction of reference data. The solid line is 
the calculated best fitting curve to this data obtained by optimization of the fitting 
parameters stoichiometry (n), enthalpy (H) and dissociation constant (Kd) using the Microcal-
PEAQ ITC software (Malvern Panalytical). Graphs shown are representative runs while the 
average values of these parameters obtained for each protein are shown in Table 1.  
 
Figure 4 : Comparison of the actin bundling efficiency of WT and mutant actinin-1 proteins.  
(A) Representative gels showing actin present in supernatant (S) and pellet (P) following 
bundling reaction in the presence of 0.2 mM EGTA or 0.1 mM CaCl2 for WT and mutant 
actinin-1 proteins. WT (n=13)  L395Q (n=9), R738W (n=7), R752Q (n=10), G764S (n=11) and 
E769K (n=8) 
(B) Percentage actinin bound to actin in pellets in presence of 0.2 mM EGTA and 0.1 mM CaCl2 
for WT and mutant actinin-1 proteins.  Bundling efficiency is reduced in presence of CaCl2. 
(C) Percentage actin bundled in bundling reactions shown in (A). 
(D) Representative gels showing actin present in supernatant (S) and pellet (P) following 
bundling reaction in the presence of 0.2 mM EGTA for additional rod domain mutants. (n=3 
for all samples) 
(E) Percentage actinin bound to actin in pellets in the presence of 0.2 mM EGTA for additional 
rod domain mutants. 
(F) Percentage actin bundled in the reactions shown in (D). 
Quantification of results is presented as the mean ± SEM. Actin bundling and actinin binding 
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Dunnett's Test. Actin bundling and actinin binding for EGTA and CaCl2 reactions were 
compared for all samples using a paired T-test for related samples. *P<0.05, **P<0.01.   
 
Figure 5 : Cytoskeletal association of actinin-1 proteins with CMTP-associated mutations in-
cellula and actin cytoskeletal organisation in HeLa and MEG-01 cells expressing GFP-tagged 
actinin-1 proteins with CMTP-associated mutations 
(A) and (B) Cytosolic / nuclear and cytoskeletal fractions were prepared from HeLa cells 
transfected with FLAG-tagged WT or mutant actinin expression constructs.  (A) Western blot 
analysis showing the levels of FLAG-actinin in each fraction as well as demonstrating 
successful fractionation as indicated by the detection of GAPDH primarily in the cytosolic / 
nuclear fraction.  (B) Quantification of the amount of mutant FLAG-actinin relative to the WT 
protein in each fraction (normalized to actin levels).  Proteins with the CaM-like domain 
mutations G764S and E769K are present in the cytoskeletal fraction at significantly greater 
higher levels as assessed by One-Way ANOVA and post-hoc Dunnett’s Test. (** p<0.01, * 
p<0.05) (n=3)  
(C) Expression of WT and mutant actinin-GFP proteins in HeLa cells.  F-actin is stained with 
rhodamine phalloidin and actinin-1 proteins are detected through GFP fluorescence (red and 
green in merged images). The actin cytoskeleton does not appear disorganised in HeLa cells 
expressing mutant actinin-1 proteins, compared with cells expressing WT actinin-1 or 
neighbouring untransfected cells. GFP-tagged actinin-1 co-localises to a great extent with 
actin for both WT and mutant actinins. Scalebar represents 20 μm. 
(D) Quantitative analysis of the width of actin fibres in HeLa cells transfected with WT or 
mutant actinin-GFP as indicated in (C).  Statistical analysis of mean actin fibre width by One-
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Supplemental Figure 1 : Location of amino acids that are mutated in CMTP within the 
actinin protein structure 
(A) Domain organisation of the actinin-1 dimer showing the interaction of the CaM-like 
domain with the neck region of the opposing subunit that is thought to regulate actin binding 
[1,6,48]. The approximate positions of selected CMTP-linked mutations are indicated by 
arrows.  Red arrows indicate the mutations in the rod and CaM-like (CaM) domains examined 
in this study, while black arrows represent mutations in the ABD that were previously shown 
to increase actinin-1 association with F-actin [20]. 
(B) An NMR structure of the CaM-like domain of actinin-1 with calcium bound (PDB ID: 2N8Y 
[6]).  Residues that are mutated in actinin-1-linked CMTP are highlighted in red, while those 
that co-ordinate the calcium ion (blue sphere) are coloured yellow (with side chains shown).   
(C) The crystal structure of the full-length actinin-2 (PDB ID: 4D1E;[1]), highlighting the end of 
spectrin-like repeat 4 (SR4) of the rod domain and the CaM-like domain from one monomer 
and the ABD and neck region of the opposing monomer in the anti-parallel dimer.  The 
residues within actinin-2 that are equivalent to the CMTP-linked mutations in actinin-1 are 
coloured red with side chains shown (T737 = T744, R738 = R745, R752 = R759, G764 = G771, 
E769 = E776).    
(D,E,F) The crystal structure of the full-length actinin-2 (PDB ID: 4D1E;[1]), highlighting a 
region of the rod domain that includes parts of SR1 and 2 from one subunit (dark green) and 
SR3 and 4 from the other (light green).  The residues within actinin-2 that are equivalent to 
the CMTP-linked mutations in central rod domain of actinin-1 are coloured red with side 
chains shown.  D = surface representation, E = cartoon representation, F = magnified view of 
R327 showing polar contacts with three glutamate side chains  (L395 = L402, R320 = R327, 
L547 = L554). 
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Supplemental Figure 2:  Expression of WT and mutant actinin-GFP proteins in MEG-01 cells 
Although large variation in cell morphology and actin structure is observed between individual 
MEG-01 cells, GFP-tagged actinin-1 does appear to co-localise with F-actin, regardless of 
CMTP-associated mutations.  Scalebar represents 20 μm.   
 
Supplementary Materials & Methods 
Actin co-sedimentation assays 
Actin co-sedimentation assays were performed essentially as previously described [20,34]. Briefly, 2 
μM of polymerized rabbit skeletal muscle actin (Cytoskeleton Inc., AKL99) was mixed with 1 μM 
purified full-length actinin in F-actin buffer (10 mM Tris-HCl pH 7.5, 100 mM NaCl, 10 mM NaN3, 10 
mM MgCl2, 1 mM ATP, and 1 mM DTT) in the presence of 0.2 mM ethylene  glycol-bis(2-
aminoethylether) tetra-acetic acid (EGTA) for analysis of actinin in the calcium-unbound state or 0.1 
mM CaCl2 for analysis of actinin in the calcium-bound state.  For all WT and mutant actinin proteins, 
a control actin-free reaction was carried out to account for artefactual sedimentation of actinin. 
One actin-only control was also carried out per experimental replicate and run on the same gel as 
experimental samples.  Reactions, in a total volume of 100 μL, were incubated for 30 min at 30 ℃ 
and bundled actin was then pelleted by centrifugation at 16,000 x g at 30 ℃.  Pellets and 
supernatants were analysed on SDS-polyacrylamide gels stained using GelCodeTM BlueSafe Protein 
Stain (Thermo Scientific).  Gels were imaged and bands were quantified using Odyssey Image Studio 
Software (LI-COR Biosciences). Sedimented actin in actinin-free control reaction and sedimented 
actinin in actin-free control reactions were subtracted from experimental reactions. Actin bundling, 
as well as the actin-binding ability of WT and mutant actinins in the presence and absence of 
calcium was determined by quantifying the percentage of actin or actinin sedimented in pellets of 
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Cytoskeletal purification assays 
Purification of cytoskeletal fractions from HeLa cells  was carried out largely as previously described 
[20,35]. HeLa cells (0.4 x 106 cells per plate) were plated on 6 cm dishes and grown for 24 hours at 
37 ℃ in DMEM, 10% FBS, with Penicillin/Streptomycin media. At 24 hours, cells were 40 - 50% 
confluent and media was replaced with 1.7 mL antibiotic-free DMEM, 10% FBS media per plate. 
Cells were transfected with 2 μg of pCMV-NFLAG plasmid DNA encoding actinin-1 with an amino-
terminal FLAG epitope tag and 0.5 μg pEGFP plasmid DNA that expresses green fluorescent protein 
as a transfection and fractionation control. DNA was suspended in 300 μL OptiMEM media and 2 μL 
Lipofectamine and added to 1.7 mL media per plate. Media was changed 16 hours post transfection 
and cytoskeletal purification was carried out 36 hours post-transfection.  Media was removed and 
plates were placed on ice. Plates were washed twice in 800 μL PBS and washes were discarded. 200 
μL lysis buffer (50 mM PIPES pH 6.9, 50 mM NaCl, 5% Glycerol, 0.1% NP-40, 0.1% Triton X-100, 0.1% 
Tween 20) was added to the plates on ice and the plates were rocked for 1.5 minutes before 
removing and retaining lysate. 800 μL wash buffer (50 mM Tris-HCl pH 7.5) was used to rinse plates 
on ice following lysis and this wash was discarded. The plates were removed from ice and 100 μL 
nuclease buffer (10 mM MgCl2, 2 mM CaCl2, 10 U/mL benzonase, 50 mM Tris-HCl pH 7.5) was added 
to the centre of each plate and allowed to flow to edges of plate. The nuclease buffer was allowed 
to incubate at room temperature for 10 minutes and was pipetted off and returned to the centre of 
plates at 2.5 minute intervals. The nuclease buffer was removed following incubation and retained. 
Lysis buffer was added back onto plates on ice (without any rinsing) and plates were rocked very 
gently for 0.5 minutes. The lysis buffer was then removed and added to the nuclease buffer and 
retained as the “cytosolic / nuclear fraction”. The plates were then rinsed with 800 μL lysis buffer on 
ice and this rinse was discarded. The plates were then washed with 800 μL wash buffer three times 
on ice. The plates were then removed from ice and 100 μL 1% SDS was added and the “cytoskeletal 
fraction” was collected by pipetting. All fractions contained protease (Complete protease 
inhibitor cocktail (without EDTA) (Roche)) and phosphatase inhibitors (5 mM NaF and 2 mM 
Na3VO4).  The cytosolic / nuclear fraction and cytoskeletal fraction were assessed by SDS-PAGE and 
western blotting. Fractionation efficiency was assessed by western blotting using an anti-GAPDH 
antibody (1:3000 - Sigma, G9545), and in some cases an anti-GFP antibody (1:1500 - Abcam, ab290), 
both of which were predominantly found in the cytosolic / nuclear fraction. Blotting using anti--
actin antibody (1:3000 - Sigma, A5441) was used as a loading control. Stability of actin-actinin 
association was assessed by detection and quantification of FLAG-tagged actinin in both fractions by 
anti-FLAG antibody (1:1500 - Sigma, F3165). Detection was achieved using an Odyssey infrared 
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Actin and FLAG signal was quantified using ImageJ [36] and Image Studio (LI-COR Biosciences) 
software respectively. FLAG signal was normalised to actin for all samples and all samples were 
expressed as a normalised ratio with respect to the WT sample of that run.  
 
Immunofluorescence studies in the MEG-01 megakaryocyte cell line 
MEG-01 (DSMZ, ACC 364) cells were grown in RPMI-1640, 10% FBS with Penicillin, Streptomycin 
media for 12 days with differentiation using phorbol 12-myristate 13-acetate (PMA) at 1 ng/mL on 
days 1-3 and 10 ng/mL on days 3-12, with a complete media change every 2-3 days. On day 10, 
media was changed to RPMI-1640, 10% FBS and 0.5 x 106 cells were plated on glass-bottomed 
dishes. Transfection was carried out using 1 μg Actinin-1-GFP plasmid with 1 μL Lipofectamine-2000 
in 100 μL OptiMEM per dish in 1 mL of culture. On day 11, dishes were supplemented with an 
additional 1 mL of media. On day 12, media was removed, and adhered cells were fixed and stained 
as described for HeLa cells. Glass component of dishes were removed and mounted on coverslips as 
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